Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 5:46 AM ET


Company Overview of Sirius Genomics Inc.

Executive Profile

Jim Heppell LLB

Founder and Director, Sirius Genomics Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Mr. Jim Heppell, LLB, serves as the President and Fund Manager of BC Advantage (VCC) Funds. Mr. Heppell has acted as a director, officer or advisor to approximately one-third of the life science companies that have spun out of BC universities. He has also worked with a number of US life science companies. He is Founder of Sirius Genomics Inc. Mr. Heppell serves as the Chairman of the Board for Inovio Biomedical (AMEX:INO) and a director of Protox Therapeutics (TSX-V:PRX) ...

Corporate Headquarters

1125 Howe Street
Vancouver, British Columbia V6Z 2K8


Phone: 604-484-7195
Fax: 604-484-7190

Board Members Memberships

Founder and Director


University Of British Columbia
University Of British Columbia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sirius Genomics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at